Featured Articles

  1. ICH E6(R3) Is Here: What Your Centralized Monitoring Strategy Needs 3/9/2026

    ICH E6(R3) turns best practices into regulatory mandates. Learn how to maintain sponsor accountability and implement proportionate centralized monitoring through a unified, auditable data layer.

  2. Offline eCOA: The Real-Time Monitoring Dilemma 3/9/2026

    Balance the need for offline data safety with the necessity of real-time monitoring. Learn how to navigate new regulatory requirements for source devices while maintaining high patient compliance.

  3. Global e-Consent Matrix 3/9/2026

    Navigate complex regional regulations and identity requirements to modernize your global clinical trial enrollment. Ensure compliance and access while moving toward digital participant engagement.

  4. The Real Cost In CNS Trials: Rater Drift And Site Readiness 11/21/2025

    Learn how to build resilience into CNS trial operations with evidence-based frameworks that prioritize human factors alongside digital tools.

  5. ICH GCP E6(R3) Implementation: Practical Approaches And Real-World Considerations 11/21/2025

    Access the full brief to learn how a phased, 12–18-month approach can help you meet ICH GCP E6(R3) requirements with confidence and avoid the costly pitfalls many organizations overlook.

  6. Hospital-Based eCOA Implementation: Real Challenges In Infectious Disease Trials 11/21/2025

    This resource outlines proven strategies to reduce delays, improve compliance, and meet regulatory standards for PRO data in infectious disease studies.

  7. The EMR Interoperability Dream Vs. Clinical Research Reality 10/20/2025

    Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.

  8. Automated Evidence Generation For Regulatory-Grade RWD 10/20/2025

    Global regulatory agencies increasingly adopt Real-World Evidence, demanding higher data quality and automated AI-driven platforms to meet evolving standards and improve drug development pathways.

  9. The New Standard In Participant-Centric Trials 8/21/2025

    Clinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.

  10. Patient-Focused Data Capture For Cancer Research 8/21/2025

    In a field where innovation is constant and patient experience is pivotal, oncology demands eCOA solutions designed to balance scientific rigor with human realities.